Cargando…
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109133/ https://www.ncbi.nlm.nih.gov/pubmed/31949268 http://dx.doi.org/10.1038/s41416-019-0709-x |
| _version_ | 1783512895972179968 |
|---|---|
| author | Ribi, Karin Luo, Weixiu Colleoni, Marco Karlsson, Per Chirgwin, Jacquie Aebi, Stefan Jerusalem, Guy Neven, Patrick Di Lauro, Vincenzo Gomez, Henry L. Ruhstaller, Thomas Abdi, Ehtesham Biganzoli, Laura Müller, Bettina Barbeaux, Annelore Graas, Marie-Pascale Rabaglio, Manuela Francis, Prudence A. Foukakis, Theodoros Pagani, Olivia Graiff, Claudio Vorobiof, Daniel Maibach, Rudolf Di Leo, Angelo Gelber, Richard D. Goldhirsch, Aron Coates, Alan S. Regan, Meredith M. Bernhard, Jürg |
| author_facet | Ribi, Karin Luo, Weixiu Colleoni, Marco Karlsson, Per Chirgwin, Jacquie Aebi, Stefan Jerusalem, Guy Neven, Patrick Di Lauro, Vincenzo Gomez, Henry L. Ruhstaller, Thomas Abdi, Ehtesham Biganzoli, Laura Müller, Bettina Barbeaux, Annelore Graas, Marie-Pascale Rabaglio, Manuela Francis, Prudence A. Foukakis, Theodoros Pagani, Olivia Graiff, Claudio Vorobiof, Daniel Maibach, Rudolf Di Leo, Angelo Gelber, Richard D. Goldhirsch, Aron Coates, Alan S. Regan, Meredith M. Bernhard, Jürg |
| author_sort | Ribi, Karin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7109133 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71091332020-04-02 Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial Ribi, Karin Luo, Weixiu Colleoni, Marco Karlsson, Per Chirgwin, Jacquie Aebi, Stefan Jerusalem, Guy Neven, Patrick Di Lauro, Vincenzo Gomez, Henry L. Ruhstaller, Thomas Abdi, Ehtesham Biganzoli, Laura Müller, Bettina Barbeaux, Annelore Graas, Marie-Pascale Rabaglio, Manuela Francis, Prudence A. Foukakis, Theodoros Pagani, Olivia Graiff, Claudio Vorobiof, Daniel Maibach, Rudolf Di Leo, Angelo Gelber, Richard D. Goldhirsch, Aron Coates, Alan S. Regan, Meredith M. Bernhard, Jürg Br J Cancer Correction Nature Publishing Group UK 2020-01-16 2020-03-31 /pmc/articles/PMC7109133/ /pubmed/31949268 http://dx.doi.org/10.1038/s41416-019-0709-x Text en © The Author(s), under exclusive licence to Cancer Research UK 2020 https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Ribi, Karin Luo, Weixiu Colleoni, Marco Karlsson, Per Chirgwin, Jacquie Aebi, Stefan Jerusalem, Guy Neven, Patrick Di Lauro, Vincenzo Gomez, Henry L. Ruhstaller, Thomas Abdi, Ehtesham Biganzoli, Laura Müller, Bettina Barbeaux, Annelore Graas, Marie-Pascale Rabaglio, Manuela Francis, Prudence A. Foukakis, Theodoros Pagani, Olivia Graiff, Claudio Vorobiof, Daniel Maibach, Rudolf Di Leo, Angelo Gelber, Richard D. Goldhirsch, Aron Coates, Alan S. Regan, Meredith M. Bernhard, Jürg Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial |
| title | Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial |
| title_full | Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial |
| title_fullStr | Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial |
| title_full_unstemmed | Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial |
| title_short | Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial |
| title_sort | correction: quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the sole randomised phase 3 trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109133/ https://www.ncbi.nlm.nih.gov/pubmed/31949268 http://dx.doi.org/10.1038/s41416-019-0709-x |
| work_keys_str_mv | AT ribikarin correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT luoweixiu correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT colleonimarco correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT karlssonper correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT chirgwinjacquie correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT aebistefan correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT jerusalemguy correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT nevenpatrick correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT dilaurovincenzo correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT gomezhenryl correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT ruhstallerthomas correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT abdiehtesham correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT biganzolilaura correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT mullerbettina correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT barbeauxannelore correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT graasmariepascale correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT rabagliomanuela correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT francisprudencea correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT foukakistheodoros correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT paganiolivia correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT graiffclaudio correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT vorobiofdaniel correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT maibachrudolf correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT dileoangelo correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT gelberrichardd correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT goldhirscharon correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT coatesalans correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT reganmeredithm correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT bernhardjurg correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial AT correctionqualityoflifeunderextendedcontinuousversusintermittentadjuvantletrozoleinlymphnodepositiveearlybreastcancerpatientsthesolerandomisedphase3trial |